KH

Kaisheng Huang

COO/CQO

RemeGen荣昌生物


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
RemeGen荣昌生物
Industry
pharmaceuticals
Employees
33.0
Seniority
C suite

Technologies

Mobile Friendly Nginx Baidu Ads

Keywords

adc and pharmaceutical manufacturing first-in-class vegf fgf fda her2 pd-1 annals of oncology jpm sabcs clinical trials oncology targeted therapy biologics cancer research immunotherapy oncology pipeline therapeutic agents drug development biosimilars cancer treatment her2-positive pipeline candidates innovative therapies patient outcomes precision medicine cancer biomarkers biotechnology therapeutic development oncology solutions cancer diagnostics treatment efficacy monoclonal antibodies research & development regulatory approvals therapeutic innovation oncology conferences scientific publications clinical efficacy cancer therapies drug discovery biopharmaceuticals targeted treatments healthcare advancements personalized oncology cancer immunotherapy treatment strategies clinical effectiveness pharmaceuticals medical health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans